Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells

被引:0
|
作者
Xi-Ping Tang [1 ]
Guo-Du Tang [1 ]
Chun-Yun Fang [1 ]
Zhi-Hai Liang [1 ]
Lu-Yi Zhang [1 ]
机构
[1] Department of Gastroenterology,First Affiliated Hospital,Guangxi Medical University
基金
中国国家自然科学基金;
关键词
Ginsenoside Rh2; Human pancreatic cancer Bxpc-3 cell; Proliferation; Apoptosis; Migration;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
AIM:To investigate the effects of ginsenoside Rh2 on the human pancreatic cancer cell line Bxpc-3.METHODS:The human pancreatic cancer cell line Bxpc-3 was cultured in vitro and treated with or without ginsenoside Rh2.Growth rates for Bxpc-3 cells were assessed by methyl thiazolyl tetrazolium(MTT) and colony formation assays.Cell cycle changes were analyzed by flow cytometry.Apoptosis was measured by flow cytometry and Hoechst 33258 fluorescence staining.A scratch assay and a Matrigel invasion assay were used to detect cell migration and invasion.Expression of Bax,Bcl-2,survivin,cyclin D1,matrix metalloproteinase(MMP)-2,MMP-9,cleaved caspase-3,caspase-8,and caspase-9 mRNA were determined by reverse transcriptase-polymerase chain reaction(RT-PCR).Bax,Bcl-2,survivin,cyclin D1,cleaved caspase-3,caspase-8 and caspase-9 protein levels were examined by western blotting.Expression of MMP-2 and MMP-9 proteins in culture supernatants were determined by enzymelinked immunosorbent assay(ELISA).RESULTS:Rh2 significantly inhibited Bxpc-3 cell proliferation in a dose-and time-dependent manner,as evaluated by the MTT(P < 0.05) and colony formation assays(P < 0.05).Compared to the control group,Rh2 significantly increased the percentage of Bxpc-3 cells in the G 0 /G 1 phase from 43.32% ± 2.17% to 71.32% ± 1.16%,which was accompanied by a decrease in S phase(from 50.86% ± 1.29% to 28.48% ± 1.18%) and G 2 /M phase(from 5.81% ± 1.19% to 0.20% ± 0.05%) in a dose-dependent manner(P < 0.05),suggesting that Rh2 arrested cell cycle progression at the G 0 /G 1 phase,as measured by flow cytometry.Compared to the control group,cells treated with Rh2 showed significantly higher apoptosis ratios in a dosedependent manner(percentage of early apoptotic cells:from 5.29% ± 2.28% to 38.90% ± 3.42%(F = 56.20,P < 0.05);percentage of late apoptotic cells:from 4.58% ± 1.42% to 36.32% ± 2.73%(F = 86.70,P < 0.05).Rh2 inhibited Bxpc-3 cell migration and invasion,as detected by scratch wound healing assay and Matrigel invasion assay [percentages of scratch wound healing for 12 h,24 h and 48 h(control vs experimental group):37.3% ± 4.8%vs 18.30% ± 1.65%,58.7% ± 3.5% vs 38.00% ± 4.09% and 93.83% ± 4.65% vs 65.50% ± 4.09%,respectively;t = 6.489,t = 6.656 and t = 7.926,respectively,P < 0.05;the number of cells invading at various concentrations(0 μmol/L,35 μmol/L,45 μmol/L and 55 μmol/L):81.10 ± 9.55,46.40 ± 6.95,24.70 ± 6.88 and 8.70 ± 3.34,respectively(F = 502.713,P < 0.05)].RT-PCR,western blotting or ELISA showed that mRNA and protein expression of Bax,cleaved caspase-3 and caspase-9 were upregulated(P < 0.05),while mRNA and protein expression of Bcl-2,survivin,cyclin D1,MMP-2 and MMP-9 were downregulated(P < 0.05).CONCLUSION:Ginsenoside Rh2 inhibits proliferation,migration and invasion and induces apoptosis of the human pancreatic cancer cell line Bxpc-3.
引用
收藏
页码:1582 / 1592
页数:11
相关论文
共 50 条
  • [31] Ginsenoside Rh2 Improves Learning and Memory in Mice
    Hou, Jingang
    Xue, Jianjie
    Lee, Mira
    Liu, Lei
    Zhang, Dongliang
    Sun, Mengqi
    Zheng, Yinan
    Sung, Changkeun
    JOURNAL OF MEDICINAL FOOD, 2013, 16 (08) : 772 - 776
  • [32] Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells
    Liu, Jie
    Shimizu, Kuniyoshi
    Yu, Hongshan
    Zhang, Chunzhi
    Jin, Fengxie
    Kondo, Ryuichiro
    FITOTERAPIA, 2010, 81 (07) : 902 - 905
  • [33] Uptake and metabolism of ginsenoside Rh2 and its aglycon protopanaxadiol by Caco-2 cells
    Xie, HT
    Wang, GJ
    Chen, M
    Jiang, XL
    Li, H
    Lv, H
    Huang, CR
    Wang, R
    Roberts, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (02) : 383 - 386
  • [34] Transcriptome Analyses of the Anti-Proliferative Effects of 20(S)-Ginsenoside Rh2 on HepG2 Cells
    Zhang, Ji
    Li, Weibo
    Yuan, Qiaoyun
    Zhou, Jing
    Zhang, Jianmei
    Cao, Yufeng
    Fu, Guangbo
    Hu, Weicheng
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [35] Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells
    Kim, So-Young
    Kim, Dong-Hyun
    Han, Sang-Jun
    Hyun, Jin-Won
    Kim, Hee-Sun
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (11) : 1642 - 1651
  • [36] How Does Ginsenoside Rh2 Mitigate Adipogenesis in Cultured Cells and Obese Mice?
    Zhang, Longyun
    Virgous, Carlos
    Si, Hongwei
    MOLECULES, 2020, 25 (10):
  • [37] Ginsenoside Rh2 Inhibits Angiogenesis in Prostate Cancer by Targeting CNNM1
    Huang, Yaqiang
    Huang, Hongxing
    Han, Zhaodong
    Li, Wei
    Mai, Zhipeng
    Yuan, Runqiang
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2019, 19 (04) : 1942 - 1950
  • [38] Synthesis and anti-cancer cell activity of pseudo-ginsenoside Rh2
    Qian, Guangtao
    Wang, Zhicai
    Zhao, Jinyu
    Li, Dandan
    Gao, Wei
    Wang, Baohui
    Sui, Dayuan
    Qu, Xiangru
    Chen, Yanping
    STEROIDS, 2014, 92 : 1 - 6
  • [39] Ginsenoside Rh2 inhibits thyroid cancer cell migration and proliferation via activation of miR-524-5p
    Jiang, Shan
    Yan, Jiqi
    Chen, Xingsheng
    Xie, Qingji
    Lin, Wei
    Lin, Ting
    Li, Qinyu
    ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (01) : 164 - 170
  • [40] Ginsenoside Rh2 Suppresses Neovascularization in Xenograft Psoriasis Model
    Zhou, Jing
    Gao, Yunlu
    Yi, Xuemei
    Ding, Yangfeng
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 36 (03) : 980 - 987